SecBot SecBot
8-K ·Filed Apr 14, 2026

CDXS

CODEXIS, INC.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001193125-26-154866
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

No immediate trading implications; monitor for any subsequent governance changes or shifts in committee leadership, particularly in science and strategy oversight given Dr. Martinborough's continued role as Chair.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
CDXS ▼ -1.22% at T+60d
NEUTRAL call -1.22% · α vs SPY -9.36% · entry $2.46 → $2.43
Entry = T+0 close
Apr 14, 2026
via day close
T+1d
+3.25%
call +3.25% · α +3.00%
$2.54
settled 7mo ago
T+5d
+0.41%
call +0.41% · α -1.23%
$2.47
settled 6mo ago
T+20d
+3.25%
call +3.25% · α -2.79%
$2.54
settled 6mo ago
T+60d
-1.22%
call -1.22% · α -9.36%
$2.43
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Codexis, Inc. reported the resignation of board member Dennis Wolf and a reclassification of Dr. Esther Martinborough from Class II to Class III director to rebalance board composition. The changes were administrative and did not involve executive departures or disagreements.

Key Facts

  • Dennis Wolf resigned from the Board of Directors effective April 8, 2026, with no reported disagreement with the company.
  • Dr. Esther Martinborough resigned as a Class II director and was re-elected as a Class III director effective April 10, 2026, to rebalance board class membership.
  • The board now consists of three directors in each class (I, II, and III), maintaining equal representation.
  • Dr. Martinborough continues in her roles on the Compensation, Strategy, and Science & Technology Committees, remaining Chair of the Science & Technology Committee.

Financial Impact

No financial impact disclosed; changes are structural and administrative.

governanceboard composition

Risk Factors

  • Minimal risk from director turnover, as resignation was amicable and rebalancing was internal.
  • Potential for minor investor concern if board stability is questioned, though no evidence of discord is present.

Market Snapshot

Exchange
Nasdaq
Sector
Industrial Organic Chemicals

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-154866
Document: 0001193125-26-154866-index-headers.html0001193125-26-154866
Document: 0001193125-26-154866-index.html0001193125-26-154866
Document: 0001193125-26-154866.txt0001193125-26-154866
8 reports for CDXS
Performance horizon
100% Hit rate @ T+60 4 of 4 directional calls Went positive at some point 4 of 5 best @ T+60▲ +154.90%Feb 28, 2026
Filters
Rows
Reports for CDXS — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
Institutional Cluster
BEARISH ★ 4/10
$1.29awaiting T+60—$1.30 (−0.78%)
Oct 13, 2026
13d ago
144
NEUTRAL ★ 2/10
$1.29awaiting T+60—$1.30 (+0.78%)
Oct 13, 2026
13d ago
144
NEUTRAL ★ 2/10
$1.29awaiting T+60—$1.30 (+0.78%)
Jul 27, 2026
13w ago
8-K
BEARISH ★ 6/10
$1.50 $1.29▲ +14.00%▲ +18.35%$1.30 (+13.33%)
Jul 24, 2026
13w ago
424B5
BEARISH ★ 6/10
$1.55 $1.32▲ +14.84%▲ +18.54%$1.30 (+16.13%)
Jul 23, 2026
13w ago
Press Release
BEARISH ★ 6/10
$1.48 $1.32▲ +10.81%▲ +14.54%$1.30 (+12.16%)
Apr 14, 2026
27w ago
8-K
NEUTRAL ★ 3/10
$2.46 $2.43▼ −1.22%▼ −9.36%$1.30 (−47.15%)
Feb 28, 2026
34w ago
Institutional Cluster
BULLISH ★ 7/10
$1.02 $2.60▲ +154.90%▲ +145.58%$1.30 (+27.45%)
Showing 8 of 8

US Market Status

Market Closed — Opens Wed (9h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 14, 2026